期刊文献+

人源抗TROP2全分子抗体IgG的真核表达及对胰腺癌细胞增殖的抑制作用 被引量:2

Eukaryotic expression of human anti-TROP2 antibody IgG and its inhibitory effect on cell proliferation of pancreatic cancer
下载PDF
导出
摘要 目的:以人源抗TROP2抗体Fab基因为模板,构建人源抗TROP2全分子抗体IgG真核表达系统,观察人源抗TROP2全分子抗体IgG对胰腺癌细胞增殖的抑制作用。方法:分别扩增抗TROP2抗体的重链和轻链基因,构建人源抗TROP2全分子抗体IgG的重组表达载体pWS-anti-TROP2,转染CHO dhfr-细胞,加MTX筛选抗体表达量高的单克隆株,Protein G亲和柱纯化,获得人源抗TROP2全分子抗体IgG。SDS-PAGE、Western blot、ELISA、免疫荧光和流式细胞术等方法鉴定人源抗TROP2全分子抗体IgG并分析其免疫学活性。MTT法分析人源抗TROP2全分子抗体IgG对胰腺癌细胞BxPC-3的增殖抑制作用。结果:成功构建了人源抗TROP2全分子抗体IgG的真核表达系统,表达并纯化人源抗TROP2全分子抗体IgG。经鉴定,抗体的轻链与重链大小与预期一致,可与TROP2蛋白特异性结合,效价可达1∶6 400。MTT检测结果表明,人源抗TROP2全分子抗体IgG对胰腺癌BxPC3细胞的增殖有明显的抑制作用,且呈时效、量效依赖关系。结论:本研究成功构建了人源抗TROP2全分子抗体IgG的真核表达系统,并证明此抗体可特异性识别胰腺癌细胞表面的TROP2蛋白,且对胰腺癌细胞的增殖有明显的抑制作用。 Objective:To construct a eukaryotic expression system of human anti-TROP2 antibody IgG by using human anti-TROP2Fab antibody gene as template,so as to study its inhibition of pancreatic cancer cell proliferation. Methods:The recombinant expression vector of human anti-TROP2 antibody IgG,named as pWS-anti-TROP2,was established by amplifying the heavy chain and light chain genes of human anti-TROP2 antibody IgG,respectively. pWS-anti-TROP2 plasmids were transfected into CHO dhfr-cell lines,and the monoclonal cell strains with high antibody expression were harvested by MTX screening. Then,human anti-TROP2antibody IgG was obtained using Protein G affinity purification. The identification and immunological characteristics of the human anti-TROP2 antibody IgG were analyzed by several methods,including sodium dodecyl sulfate polyacrylamide gel electrophoresis(SDS-PAGE),Westent blotting assay,enzyme-linked immuno sorbent assay(ELISA),flow cytometry method(FCM) and immuno fluorescence assay. The inhibition function of human anti-TROP2 antibody IgG in proliferation of BxPC3 cells was analyzed by MTT assay. Results:The eukaryotic expression system of human anti-TROP2 antibody IgG was constructed successfully. Purified human anti-TROP2 antibody IgG was obtained. The molecular weight of light and heavy chains of human anti-TROP2 antibody IgG are consistent with expected results,the antibodies could bind to TROP2 protein specifically,and the antibody titer reached 1∶6 400. MTT assay demonstrated that human anti-TROP2 antibody IgG played a significant pole in inhibiting BxPC3 cell proliferation,and the inhibition ratio was gradually increased with prolonged time and increased antibody dose. Conclusion:In the study,the eukaryotic expression system of human anti-TROP2 antibody IgG was established successfully,and it was proved that the antibody could recognize native TROP2 protein on pancreatic cancer cell surface specificially and play an important role in inhibiting the proliferation of pancreatic cancer cells.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2014年第7期863-869,882,共8页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金项目(81101704) 南京市医学科技发展项目(ZKX12025)
关键词 TROP2 真核表达系统 CHO dhfr-细胞 胰腺癌 TROP2 eukaryotic expression system CHO dhfr-cell line pancreatic cancer
  • 相关文献

参考文献11

二级参考文献171

共引文献31

同被引文献21

  • 1朱进,王辛,焦永军,冯振卿,曹伯良,管晓虹.高亲和力抗Met人源基因工程抗体scFv的筛选与特性分析[J].中国肿瘤生物治疗杂志,2006,13(6):417-422. 被引量:6
  • 2Farias TP, Dias FL, Lima RA, et al. Prognostic factors and outcome for nasopharyngeal carcinoma[J]. Arch Oto- laryngol Head Neck Surg, 2003,129 (7) : 794-799.
  • 3Oshima Y, Yajima S, Yamazaki K, et al. Angiogenesis- related factors are molecular targets for diagnosis and treatment of patients with esophageal carcinoma[J]. Ann Thorac Cardiovasc Surg, 2010, 16(6) : 389-393.
  • 4Matsumoto K, Nakamura T. NK4 (HGF-antagonist/angio- genesis inhibitor) in cancer biology and therapeutics[J]. Cancer Sci, 2003,94(4) : 321-327.
  • 5Ma PC, Schaefer E, Christensen JG, et al. A selective small molecule c-MET inhibitor, PHA665752, cooper- ates with rapamycin[J]. Clin Cancer Res,2005,11 (6): 2312-2319.
  • 6Deckert PM. Current constructs and targets in clinical de- velopment for antibody-based cancer therapy[J]. CUlT Drug Targets, 2009,10(2) : 158-175.
  • 7Chen X, Ding G, Gao Q, et al. A human anti-c-Met Fab fragment conjugated with doxorubicin as targeted chemotherapy for hepatocellular carcinoma [J]. PLoS One, 2013,8(5) : e63093.
  • 8Maulik G, Shrikhande A, Kijima T, et al. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition[J]. Cytokine Growth Factor Rev, 2002,13 ( 1 ) : 41-59.
  • 9Bottaro DP,Rubin JS,Faletto DL,et al. Identification of the hepatoeyte growth factor receptor as the c-Mct proto-on- congent product[J]. Science, 1991,251 (4995) : 802-804.
  • 10Mizuno S, Nakamura T. HGF-MET cascade, a key target for inhibiting cancer metastasis :the impact of NK4 dis- covery on cancer biology and therapeutics[J]. Int J Mol Sei,2013,14( 1 ) :888-919.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部